DTC Ads Being Pushed As Drug Safety Problem By Sen. Kennedy
This article was originally published in The Pink Sheet Daily
Executive Summary
Massachusetts Democrat's statements at a Health Committee hearing suggest he will push for drug safety legislation to limit direct-to-consumer advertising for newly approved drugs. He also urges legislation granting FDA authority to require drug labeling changes and post-marketing safety studies.
You may also be interested in...
Hurricane Legislation Tables Drug Safety Issues
Congress will likely postpone consideration of drug safety issues to address emergency legislation relating to Hurricane Katrina, Senate Budget Committee Senior FDA Health Counsel Peggy Binzer said at the Food & Drug Law Institute conference on promotion and advertising Sept. 19
Hurricane Legislation Tables Drug Safety Issues
Congress will likely postpone consideration of drug safety issues to address emergency legislation relating to Hurricane Katrina, Senate Budget Committee Senior FDA Health Counsel Peggy Binzer said at the Food & Drug Law Institute conference on promotion and advertising Sept. 19
Independent Drug Safety Oversight Could Lead To Over-Reactions - Enzi
Legislation establishing an independent drug safety oversight group for FDA could result in over-reactions to drug safety signals, Senate Health Committee Chairman Michael Enzi (R-Wyo.) told the Food & Drug Law Institute annual conference April 7 in Washington, D.C